Blog

Sep 16, 2019

Nanoparticles used to transport anti-cancer agent to cells

Posted by in categories: biotech/medical, engineering, nanotechnology

Scientists from the University of Cambridge have developed a platform that uses nanoparticles known as metal-organic frameworks to deliver a promising anti-cancer agent to cells.

Research led by Dr. David Fairen-Jimenez, from the Cambridge Department of Chemical Engineering and Biotechnology, indicates (MOFs) could present a viable platform for delivering a potent anti-cancer agent, known as siRNA, to .

Small interfering ribonucleic acid (siRNA), has the potential to inhibit overexpressed cancer-causing genes, and has become an increasing focus for scientists on the hunt for new cancer treatments.

Leave a reply